StreetInsider.com News Articles

Oklo (OKLO) PT Lowered to $59 at Barclays

Wed, 21 Oct 2026 03:16:04 -0400

Barclays analyst Christine Cho lowered the price target on Oklo (NYSE: OKLO) to $59.00 (from $76.00) while maintaining a Overweight rating.

Form 4 Oklo Inc. For: Oct 17 Filed by: Narayanadas Vivek

Tue, 20 Oct 2026 16:26:00 -0400

si-local-file:///var/storage/secattach/20261020/27210792.html

Form 144 Oklo Inc. Filed by: Narayanadas Vivek

Tue, 20 Oct 2026 09:43:00 -0400

si-local-file:///var/storage/secattach/20261020/27208205.html

Form 144 Oklo Inc. Filed by: Narayanadas Vivek

Mon, 19 Oct 2026 15:16:00 -0400

si-local-file:///var/storage/secattach/20261019/27203502.html

Oklo (OKLO) PT Lowered to $49 at Piper Sandler

Mon, 19 Oct 2026 09:15:57 -0400

(Updated - October 19, 2026 9:15 AM EDT)

Piper Sandler analyst Dimple Gosai lowered the price target on Oklo (NYSE: OKLO) to $49.00 (from $55.00) while maintaining a Overweight rating.

The analyst commented: "What we're looking for - Aurora INL, A3F progress, NRC application for Pike County, Groves-2 timing: Construction is ramping up at INL following DOE PDSA, the DOE equivalent to a construction permit. Details on plant CapEx, PPAs and fuel costs are all top of mind, but investors must wait until CMD in Spring 2027 for fuller guidance. We expect mgmt to give an update on NRC submission timing for

Oklo (OKLO) PT Lowered to $49 at Piper Sandler

Mon, 19 Oct 2026 09:15:57 -0400

(Updated - October 19, 2026 9:15 AM EDT)

Piper Sandler analyst Dimple Gosai lowered the price target on Oklo (NYSE: OKLO) to $49.00 (from $55.00) while maintaining a Overweight rating.

Form 4 Oklo Inc. For: Oct 13 Filed by: Hanson John

Thu, 15 Oct 2026 16:24:00 -0400

si-local-file:///var/storage/secattach/20261015/27193695.html

Form 4 Oklo Inc. For: Oct 13 Filed by: Renner Alexandra

Thu, 15 Oct 2026 16:23:00 -0400

si-local-file:///var/storage/secattach/20261015/27193682.html

Form 144 Oklo Inc. Filed by: Renner Alexandra

Wed, 14 Oct 2026 15:26:00 -0400

si-local-file:///var/storage/secattach/20261014/27186878.html

Form 4 Oklo Inc. For: Oct 08 Filed by: Narayanadas Vivek

Tue, 13 Oct 2026 16:40:00 -0400

si-local-file:///var/storage/secattach/20261013/27181636.html

Oklo selected for DOE isotope production initiative with Groves 2

Tue, 13 Oct 2026 07:01:36 -0400

Oklo Inc. (NYSE: OKLO) has been selected by the U.S. Department of Energy's (DOE) National Reactor Innovation Center (NRIC) to advance its Groves 2 Forge isotope production and processing pilot facility as part of the Nuclear Energy Launch Pad initiative.

The DOE and NRIC selected 12 developers across 13 projects for the initiative, which provides a pathway for domestic reactor development and nuclear fuel cycle advancements. Groves 2 Forge is planned to integrate reactor irradiation with hot-cell processing capabilities, including isotope separation, product recovery, packaging, and transportation. The facility will initially focus on producing lutetium-177, an isotope used in targeted cancer

Oklo to Advance Groves 2 Forge as Part of U.S. Department of Energy’s Nuclear Energy Launch Pad Selection

Tue, 13 Oct 2026 07:00:00 -0400

U.S. Department of Energy’s National Reactor Innovation Center picks 12 developers on 13 new projects to take part in the Nuclear Energy Launch Pad initiative.
Oklo plans to build on the rapid deployment of the Groves Isotope Test Reactor in Texas with Groves 2 Forge, an isotope production and processing pilot facility.
Groves 2 Forge to initially focus on producing lutetium-177, an isotope used in targeted cancer treatments.
Oklo plans to transition Groves 2 Forge from pilot operations to commercial-scale isotope production with the appropriate U.S. Nuclear Regulatory Commission licenses for commercial operation.

SANTA CLARA, Calif.--(BUSINESS WIRE)-- Oklo Inc. (NYSE:

Oklo to Advance Groves 2 Forge as Part of U.S. Department of Energy’s Nuclear Energy Launch Pad Selection

Tue, 13 Oct 2026 07:00:00 -0400

U.S. Department of Energy’s National Reactor Innovation Center picks 12 developers on 13 new projects to take part in the Nuclear Energy Launch Pad initiative.
Oklo plans to build on the rapid deployment of the Groves Isotope Test Reactor in Texas with Groves 2 Forge, an isotope production and processing pilot facility.
Groves 2 Forge to initially focus on producing lutetium-177, an isotope used in targeted cancer treatments.
Oklo plans to transition Groves 2 Forge from pilot operations to commercial-scale isotope production with the appropriate U.S. Nuclear Regulatory Commission licenses for commercial operation.

SANTA CLARA, Calif.--(BUSINESS WIRE)-- Oklo Inc. (NYSE:

Form 144 Oklo Inc. Filed by: Narayanadas Vivek

Fri, 09 Oct 2026 15:14:00 -0400

si-local-file:///var/storage/secattach/20261009/27171253.html

Form 4 Oklo Inc. For: Oct 06 Filed by: Narayanadas Vivek

Thu, 08 Oct 2026 16:15:00 -0400

si-local-file:///var/storage/secattach/20261008/27167184.html

Form 4 Oklo Inc. For: Oct 03 Filed by: Narayanadas Vivek

Tue, 06 Oct 2026 16:08:00 -0400

si-local-file:///var/storage/secattach/20261006/27155530.html

Form 144 Oklo Inc. Filed by: Narayanadas Vivek

Tue, 06 Oct 2026 10:48:00 -0400

si-local-file:///var/storage/secattach/20261006/27153908.html

Form 4 Oklo Inc. For: Oct 01 Filed by: DeWitte Jacob

Mon, 05 Oct 2026 16:02:00 -0400

si-local-file:///var/storage/secattach/20261005/27148611.html

Form 4 Oklo Inc. For: Oct 01 Filed by: Cochran Caroline

Mon, 05 Oct 2026 16:02:00 -0400

si-local-file:///var/storage/secattach/20261005/27148614.html

Form 4 Oklo Inc. For: Oct 01 Filed by: Bealmear Richard Craig

Mon, 05 Oct 2026 16:01:00 -0400

si-local-file:///var/storage/secattach/20261005/27148597.html

Form 144 Oklo Inc. Filed by: Narayanadas Vivek

Mon, 05 Oct 2026 15:15:00 -0400

si-local-file:///var/storage/secattach/20261005/27148423.html

Canaccord Reiterates Buy Rating on Oklo (OKLO)

Mon, 05 Oct 2026 05:34:59 -0400

Canaccord analyst George Gianarikas reiterated a Buy rating and $100.00 price target on Oklo (NYSE: OKLO).

The analyst comments "Revenue from Oklo’s isotope division may be quite modest for some time, but our assumptions could easily prove conservative as Groves-2 advances and plans there crystallize. Crucially, the real value now lies beyond the immediate top line: Isotopes serve as the connective tissue for Oklo’s vertically integrated model, bridging blueprint to groundbreak while generating invaluable, real-world operational intelligence. A re-renaissance is taking shape in the nuclear sector, where a handful of startups are chasing a genuinely promising future. It is a formidable

Canaccord Reiterates Buy Rating on Oklo (OKLO)

Mon, 05 Oct 2026 05:34:59 -0400

Canaccord analyst George Gianarikas reiterated a Buy rating and $100.00 price target on Oklo (NYSE: OKLO).

Form 144 Oklo Inc. Filed by: Bealmear Richard Craig

Thu, 01 Oct 2026 10:21:00 -0400

si-local-file:///var/storage/secattach/20261001/27133395.html

Piper Sandler on Oklo (OKLO): 'Groves Proves the Team Can Build; Aurora Still Drives the Stock'

Thu, 01 Oct 2026 09:39:20 -0400

Piper Sandler analyst Dimple Gosai reiterated an Overweight rating and $55.00 price target on Oklo (NYSE: OKLO).

The analyst commented: "Groves Proves the Team Can Build; Aurora Still Drives the Stock; Our Groves visit reaffirmed our confidence that Oklo can take a nuclear project from a greenfield site to first criticality on a commercial timeline. Groves took about 11 months from groundbreaking to criticality on private land, which we think is the strongest execution evidence the company has shown so far. It does not change our numbers. The stock trades on Aurora, the ~75 MWe sodium-cooled reactor targeted for INL in